Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical Trial. (Q49499053)
Jump to navigation
Jump to search
scientific article published in February 2018
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical Trial. |
scientific article published in February 2018 |
Statements
1 reference
Rationale and Design of an Adaptive Phase 2b/3 Clinical Trial of Selepressin for Adults in Septic Shock. Selepressin Evaluation Programme for Sepsis-induced Shock-Adaptive Clinical Trial. (English)
1 reference
Derek C Angus
1 reference
Donald M Yealy
1 reference
Roger J Lewis
1 reference
Pierre-François Laterre
1 reference
Anne Louise Kjølbye
1 reference
Egbert van der Meulen
1 reference
Allan Blemings
1 reference
Todd Graves
1 reference
James A Russell
1 reference
Jan E Carlsen
1 reference
Karsten Jacobsen
1 reference
Steven M Opal
1 reference
Nis A Windeløv
1 reference
Bruno François
1 reference
Anders Perner
1 reference
Peter Pickkers
1 reference
Scott M Berry
1 reference
1 February 2018
1 reference
15
1 reference
2
1 reference
250-257
1 reference
Identifiers
1 reference
1 reference